These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 311446)

  • 21. Animal models of myoclonus.
    Kanthasamy AG; Matsumoto RR; Truong DD
    Clin Neurosci; 1995-1996; 3(4):236-45. PubMed ID: 8891397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
    Pranzatelli MR; Snodgrass SR
    Neuropharmacology; 1986 Jan; 25(1):5-12. PubMed ID: 2936977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloromaphetamine.
    Growdon JH
    Neurology; 1977 Nov; 27(11):1074-7. PubMed ID: 563003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of inferior olive-climbing fibers to p,p'-DDT-induced myoclonus in rats.
    Hwang EC; Plaitakis A; Magnussen I; Van Woert MH
    Neurosci Lett; 1981 Jun; 24(1):103-8. PubMed ID: 7266934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pig.
    Chadwick D; Jenner P; Marsden CD
    Br J Pharmacol; 1979 Jul; 66(3):358-60. PubMed ID: 93500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the chronic effects of p,p'-DDT and -chlordane on brain amines.
    Hrdina PD; Singhal RL; Peters DA; Ling GM
    Eur J Pharmacol; 1972 Oct; 20(1):114-7. PubMed ID: 4637938
    [No Abstract]   [Full Text] [Related]  

  • 28. Veratramine-induced behavior associated with serotonergic hyperfunction in mice.
    Nagata R; Izumi K
    Jpn J Pharmacol; 1991 Jan; 55(1):129-37. PubMed ID: 1710297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional glycine receptor binding in the p,p'-DDT myoclonic rat model.
    Pranzatelli MR; Tkach K
    Arch Toxicol; 1992; 66(1):73-6. PubMed ID: 1316118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
    Weiner WJ; Goetz C; Westheimer R; Klawans HL
    J Neurol Sci; 1973 Dec; 20(4):373-9. PubMed ID: 4359068
    [No Abstract]   [Full Text] [Related]  

  • 31. Levodopa-induced myoclonus.
    Klawans HL; Goetz C; Bergen D
    Arch Neurol; 1975 May; 32(5):330-4. PubMed ID: 1079721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J; Richardson JC; Hornykiewicz O
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Myoclonus, methysergide, and serotonin.
    Goetz CG; Klawans HL
    Lancet; 1974 Jun; 1(7869):1284-5. PubMed ID: 4134163
    [No Abstract]   [Full Text] [Related]  

  • 34. Valproate and myoclonus.
    Chapman AG
    Adv Neurol; 1986; 43():661-74. PubMed ID: 3080855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
    Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG
    Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DDT myoclonus: sites and mechanism of action.
    Chung E; Van Woert MH
    Exp Neurol; 1984 Aug; 85(2):273-82. PubMed ID: 6378651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serotoninergic conception of myoclonic syndromes. (Review)].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(6):797-803. PubMed ID: 224629
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat.
    Stewart RM; Growdon JH; Cancian D; Baldessarini RJ
    Neuropharmacology; 1976 Aug; 15(8):449-55. PubMed ID: 1086442
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.